Related Experiment Video
Updated: Aug 11, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
Interpreting antibody identification tests with large language models: Critical role of tabular data formatting
Jiwoo Lee1,2, Yousun Chung3, Dae-Hyun Ko4
1Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Background:
Antibody identification testing is essential for preventing hemolytic transfusion reactions from unexpected red cell antibodies. Although automated interpretation is desirable to improve efficiency and consistency, conventional algorithmic approaches show limited accuracy, particularly in complex cases. Large language models (LLMs) offer a potential alternative; however, their performance is known to be sensitive to tabular data, which is a standard format for antigen profiles in antibody identification.
Study Design And Methods:
We generated 100 simulated antibody identification cases comprising single alloantibodies, dual alloantibodies, autoantibodies, and unidentifiable patterns. Seven LLMs (GPT-4o, GPT-4.1, o3, GPT-5, Gemini 2.0 Flash, Gemini 2.5 Flash, and Gemini 2.5 Pro) were evaluated. Antigen profile tables were provided using five text-based formats (Markdown, CSV, JSON, list-based, and sentence-based serialization) and as uploaded spreadsheet files. Each model interpreted all cases 10 times per format, and accuracy was assessed overall and by antibody category.
Results:
Reasoning-capable LLMs significantly outperformed non-reasoning models, achieving a median accuracy of 84.5%. Among text-based formats, sentence-based serialization yielded the highest accuracy, whereas CSV performed poorest. The maximum accuracy difference between table formats reached 40.5 percentage points. GPT-5 and o3 performed comparably when antigen profiles were supplied as uploaded spreadsheet files, achieving accuracy similar to that of the sentence-based format.
Conclusions:
Reasoning LLMs demonstrated measurable baseline capability for interpreting antibody identification results when accompanied by appropriately structured antigen profile inputs. However, performance varied markedly with data representation and case complexity, and the use of LLMs in transfusion practice should remain limited to an assistive role under specialist supervision.